IONS financials
Ionis Pharmaceuticals (IONS) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
IONS income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $944.00M | $928.00M | -$382.00M | -$381.00M | -2.38 |
| 2024 | $705.14M | $693.92M | -$475.08M | -$453.90M | -3.04 |
| 2023 | $787.65M | $778.51M | -$353.73M | -$366.29M | -2.56 |
| 2022 | $587.37M | $573.25M | -$410.19M | -$269.72M | -1.90 |
| 2021 | $810.46M | $799.61M | -$30.19M | -$28.60M | -0.20 |
| 2020 | $729.26M | $717.32M | -$172.08M | -$444.26M | -3.18 |
- IONS revenue was $944.00M in fiscal 2025, net income -$381.00M.
Updated 2026-11-02 23:12 UTC